blood pressure and heart rate variability are linked with hyperphosphatemia in chronic kidney disease patients.
this study shows that hyperphosphatemia can delay or prevent chronic kidney disease.
the study found that additional risk factors, mainly mineral and bone disorders mcs, play an essential role in developing cardiovascular diseases in patients with chronic kidney pain.
the primary research method in this study was the comparative modeling of the action of two new drugs for the treatment of hyperphosphatemia in ckd.
the literature collected in this work is evidencebased on the studys central thesis hyperphosphatemia can delay the onset of chronic kidney disease.
blood pressure and heart rate variability are linked with hyperphosphatemia in chronic kidney disease patients.